KVS Castings IPO vs Renol Polychem IPO

Comparison between KVS Castings IPO and Renol Polychem IPO.

IPO Details

KVS Castings IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Renol Polychem IPO is a SME Bookbuilding proposed to list at NSE SME.

Issue Size and Price

The total issue size of KVS Castings IPO is up to ₹26.41 Cr whereas the issue size of the Renol Polychem IPO is up to ₹24.20 Cr. The final issue price of KVS Castings IPO is ₹56.00 per share and of Renol Polychem IPO is ₹105.00 per share.

 KVS Castings IPORenol Polychem IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹53.00 per share₹100.00 per share
Issue Price (Upper)₹56.00 per share₹105.00 per share
Issue Price (Final)₹56.00 per share₹105.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size2000 shares1200 shares
Fresh Issue Size47,16,000 shares23,05,200 shares
Fresh Issue Size (Amount)up to ₹26.41 Crup to ₹24.20 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total47,16,000 shares23,05,200 shares
Issue Size Total (Amount)up to ₹26.41 Crup to ₹24.20 Cr

IPO Timetable

KVS Castings IPO opens on Sep 26, 2025, while Renol Polychem IPO opens on Jul 31, 2025. The closing date of KVS Castings IPO and Renol Polychem IPO is Sep 30, 2025, and Aug 04, 2025, respectively.

 KVS Castings IPORenol Polychem IPO
Anchor Bid DateSep 25, 2025Jul 30, 2025
Issue OpenSep 26, 2025Jul 31, 2025
Issue CloseSep 30, 2025Aug 04, 2025
Basis Of Allotment (Tentative)Oct 01, 2025Aug 05, 2025
Initiation of Refunds (Tentative)Oct 03, 2025Aug 06, 2025
Credit of Share (Tentative)Oct 03, 2025Aug 06, 2025
Listing date (Tentative)Oct 06, 2025Aug 07, 2025
Anchor Lockin End date 1Nov 05, 2025Sep 04, 2025
Anchor Lockin End date 2Jan 04, 2026Nov 03, 2025

Financials & KPIs

KVS Castings IPO P/E ratio is 11.65, as compared to Renol Polychem IPO P/E ratio of 11.54.

 KVS Castings IPORenol Polychem IPO
Financials

Company Financials (Restated)

KVS Castings Ltd.'s revenue decreased by 8% and profit after tax (PAT) rose by 11% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets47.7531.3532.01
Total Income50.4354.7057.51
Profit After Tax6.635.954.84
EBITDA9.849.007.51
NET Worth34.4525.7919.83
Reserves and Surplus20.6725.4619.51
Total Borrowing3.720.584.98
Amount in ₹ Crore

Company Financials (Restated)

Renol Polychem Ltd.'s revenue increased by 859% and profit after tax (PAT) rose by 226% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 May 202531 Mar 202531 Mar 202431 Mar 2023
Assets25.8623.4115.4910.28
Total Income12.0262.566.5241.86
Profit After Tax1.145.001.530.73
EBITDA1.607.072.181.14
NET Worth14.4713.338.692.71
Reserves and Surplus8.987.843.20
Total Borrowing5.286.952.585.36
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)96.5599.99
Promoter Shareholding (Post-Issue)70.9669.11
P/E Ratio11.6511.54
Market Cap₹105.02 Cr.₹83.41 Cr.
ROE2245.37
ROCE23.7864.18
Debt/Equity0.110.52
EPS₹4.81₹9.10
RoNW2245.37

Shares Offered

In the KVS Castings IPO Retail Individual Investors (RII) are offered 16,56,000 shares while in Renol Polychem IPO retail investors are offered 16,56,000 shares. Qualified Institutional Buyers (QIB) are offered 9,42,000 shares in KVS Castings IPO and 2,56,800 shares in Renol Polychem IPO.

 KVS Castings IPORenol Polychem IPO
Anchor Investor Reservation14,10,000 shares3,84,000 shares
Market Maker Reservation2,54,000 shares1,48,800 shares
QIB9,42,000 shares2,56,800 shares
NII7,08,000 shares3,49,200 shares
RII16,56,000 shares13,15,200 shares
Employee0 shares0 shares
Others
Total47,16,000 shares23,05,200 shares

Bids Received (Subscription)

KVS Castings IPO subscribed 4.09x in total, whereas Renol Polychem IPO subscribed 6.83x.

 KVS Castings IPORenol Polychem IPO
QIB (times)6.03x8.41x
NII (times)5.02x6.89x
Big NII (times)6.03x7.21x
Small NII (times)2.97x6.25x
RII (times)2.60x6.51x
Employee (times)
Other (times)
Total (times)4.09x6.83x

Compare with others

Compare:

KVS Castings IPO Vs Renol Polychem IPO